<http://purl.obolibrary.org/obo/GO_0006631>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

<http://www.reactome.org/biopax/63/48887#Pathway1870>
        a       <http://www.biopax.org/release/biopax-level3.owl#Pathway> , <http://purl.obolibrary.org/obo/GO_0008202> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Steroids, defined by a four-ring cyclopenta[a]phenanthrene carbon skeleton, include cholesterol and bile acids and salts, steroid hormones, and vitamin D, three groups of molecules synthesized from it. In this module, pathways for the synthesis of cholesterol from HMG-CoA (hydroxymethylglutaryl-coenzyme A) (Russell 1992), and for its conversion to bile acids and salts (Russell 2003), steroid hormones (Payne & Hales 2004), and vitamin D (Dusso et al. 2005) are annotated, together with the SREBP-mediated regulatory process that normally links the rate of cholesterol synthesis to levels of cellular cholesterol (Brown & Goldstein 2009)." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Metabolism of steroids" ;
        <http://geneontology.org/lego/hint/layout/x>
                7650 , 5700 ;
        <http://geneontology.org/lego/hint/layout/y>
                50 , 4550 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-556833" , "Edited: Jassal, B, 2007-01-24 15:15:12" , "Authored: Jassal, B, 2007-01-24 15:15:12" , "Reviewed: Jassal, Bijay, 2015-11-02" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-04-02" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/GO_0006644>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

<http://www.reactome.org/biopax/63/48887#Pathway1883>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/GO_0010025> , <http://www.biopax.org/release/biopax-level3.owl#Pathway> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Waxes are esters of long chain fatty acids and long chain fatty alcohols that play an important role in protecting the skin surface from drying and abrasion. Enzymes that catalyze two reactions of wax biosynthesis have been characterized in humans. FAR1 and FAR2 catalyze the reduction of fatty acids to fatty alcohols in the peroxisome and AWAT1 and AWAT2 catalyze the reaction of fatty alcohols and acyl-CoA in the cytosol to form wax esters. The existence of a transport process, otherwise uncharacterized, to move fatty alcohols from the peroxisome to the cytosol is inferred from the observation that cultured cells that do not normally synthesize waxes can be induced to do so by co-transfection with DNA constructs encoding FAR and AWAT enzymes (Cheng & Russell 2004a,b)." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Wax biosynthesis" ;
        <http://geneontology.org/lego/hint/layout/x>
                6350 , 5700 ;
        <http://geneontology.org/lego/hint/layout/y>
                3650 , 50 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Edited: D'Eustachio, Peter, 2015-12-09" , "Authored: D'Eustachio, Peter, 2015-12-09" , "https://reactome.org/content/detail/R-HSA-556833" , "Reviewed: Jassal, Bijay, 2016-01-29" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-04-02" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/GO_0006629>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-556833" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-04-02" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://www.reactome.org/biopax/63/48887#Pathway1794> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://www.reactome.org/biopax/63/48887#Pathway1830>
] .

<http://purl.obolibrary.org/obo/GO_0008202>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

<http://purl.obolibrary.org/obo/BFO_0000051>
        a       <http://www.w3.org/2002/07/owl#ObjectProperty> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "has part" .

<http://purl.obolibrary.org/obo/RO_0002327>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "enables" .

<http://purl.org/pav/providedBy>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://purl.obolibrary.org/obo/CHEBI_36080>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "chebi protein" .

<http://purl.obolibrary.org/obo/RO_0002406>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "directly activates (process to process)" .

<http://purl.obolibrary.org/obo/BFO_0000002>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Continuant" .

<http://purl.obolibrary.org/obo/GO_0008150>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Biological Process" .

<http://purl.obolibrary.org/obo/RO_0002334>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "regulated by" .

<http://purl.obolibrary.org/obo/BFO_0000015>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Process" .

<http://www.reactome.org/biopax/63/48887#Pathway1867>
        a       <http://www.biopax.org/release/biopax-level3.owl#Pathway> , <http://purl.obolibrary.org/obo/GO_0006665> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Sphingolipids are derivatives of long chain sphingoid bases such as sphingosine (trans-1,3-dihydroxy 2-amino-4-octadecene), an 18-carbon unsaturated amino alcohol which is the most abundant sphingoid base in mammals. Amide linkage of a fatty acid to sphingosine yields ceramides. Esterification of phosphocholine to ceramides yields sphingomyelin, and ceramide glycosylation yields glycosylceramides. Introduction of sialic acid residues yields gangliosides. These molecules appear to be essential components of cell membranes, and intermediates in the pathways of sphingolipid synthesis and breakdown modulate processes including apoptosis and T cell trafficking.<p>While sphingolipids are abundant in a wide variety of foodstuffs, these dietary molecules are mostly degraded by the intestinal flora and intestinal enzymes. The body primarily depends on de novo synthesis for its sphingolipid supply (Hannun and Obeid 2008; Merrill 2002). De novo synthesis proceeds in four steps: the condensation of palmitoyl-CoA and serine to form 3-ketosphinganine, the reduction of 3-ketosphinganine to sphinganine, the acylation of sphinganine with a long-chain fatty acyl CoA to form dihydroceramide, and the desaturation of dihydroceramide to form ceramide.<p>Other sphingolipids involved in signaling are derived from ceramide and its biosynthetic intermediates. These include sphinganine (dihydrosphingosine) 1-phosphate, phytoceramide, sphingosine, and sphingosine 1-phosphate.<p>Sphingomyelin is synthesized in a single step in the membrane of the Golgi apparatus from ceramides generated in the endoplasmic reticulum (ER) membrane and transferred to the Golgi by CERT (ceramide transfer protein), an isoform of COL4A3BP that is associated with the ER membrane as a complex with PPM1L (protein phosphatase 1-like) and VAPA or VAPB (VAMP-associated proteins A or B). Sphingomyelin synthesis appears to be regulated primarily at the level of this transport process through the reversible phosphorylation of CERT (Saito et al. 2008).<br>" ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Sphingolipid metabolism" ;
        <http://geneontology.org/lego/hint/layout/x>
                2450 ;
        <http://geneontology.org/lego/hint/layout/y>
                50 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Reviewed: Jassal, B, 2009-08-20" , "Edited: D'Eustachio, P, 2009-08-20" , "https://reactome.org/content/detail/R-HSA-556833" , "Reviewed: Hannun, YA, Luberto, C, 2009-11-18" , "Authored: D'Eustachio, P, 2009-08-20" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-04-02" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-556833" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-04-02" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://www.reactome.org/biopax/63/48887#Pathway1794> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://www.reactome.org/biopax/63/48887#Pathway1798>
] .

<http://www.reactome.org/biopax/63/48887#Pathway1795>
        a       <http://www.biopax.org/release/biopax-level3.owl#Pathway> , <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/GO_0019216> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Peroxisome proliferator-activated receptor alpha (PPAR-alpha) is the major regulator of fatty acid oxidation in the liver. PPARalpha is also the target of fibrate drugs used to treat abnormal plasma lipid levels. <br>PPAR-alpha is a type II nuclear receptor (its subcellular location does not depend on ligand binding). PPAR-alpha forms heterodimers with Retinoid X receptor alpha (RXR-alpha), another type II nuclear receptor. PPAR-alpha is activated by binding fatty acid ligands, especially polyunsaturated fatty acids having 18-22 carbon groups and 2-6 double bonds. <br>The PPAR-alpha:RXR-alpha heterodimer binds peroxisome proliferator receptor elements (PPREs) in and around target genes. Binding of fatty acids and synthetic ligands causes a conformational change in PPAR-alpha such that it releases the corepressors and binds coactivators (CBP-SRC-HAT complex, ASC complex, and TRAP-Mediator complex) which initiate transcription of the target genes.<br>Target genes of PPAR-alpha participate in fatty acid transport, fatty acid oxidation, triglyceride clearance, lipoprotein production, and cholesterol homeostasis." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)" ;
        <http://geneontology.org/lego/hint/layout/x>
                7000 , 5700 ;
        <http://geneontology.org/lego/hint/layout/y>
                50 , 4100 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Authored: May, B, 2009-05-30 16:45:51" , "https://reactome.org/content/detail/R-HSA-556833" , "Edited: May, B, 2009-05-30 16:45:51" , "Reviewed: Kersten, S, 2009-06-08" , "Edited: May, B, 2009-06-08" , "Edited: May, B, 2011-11-08" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-04-02" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/RO_0002234>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "has output" .

<http://purl.obolibrary.org/obo/RO_0002413>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "directly provides input for (process to process)" .

<http://www.reactome.org/biopax/63/48887#Pathway1833>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/GO_0006644> , <http://www.biopax.org/release/biopax-level3.owl#Pathway> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Phospholipids contain a polar head group and two long-chain fatty acyl moieties, one of which is generally unsaturated. The head group is a glycerol or serine phosphate attached to a polar group such as choline. These molecules are a major constituent of cellular membranes, where their diverse structures and asymmetric distributions play major roles in determining membrane properties (Dowhan 1997). The four major classes of phospholipids in human plasma membranes are phosphatidylethanolamine, phosphatidylserine, phosphatidylcholine, and sphingomyelin. The first three are derivatives of glycerol while sphingomyelin is a derivative of serine.<p>Here, pathways for the metabolism of glycerophospholipids, phosphphatidylinositol (PI), and sphingolipids are annotated." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Phospholipid metabolism" ;
        <http://geneontology.org/lego/hint/layout/x>
                1150 ;
        <http://geneontology.org/lego/hint/layout/y>
                50 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Authored: Williams, MG, 2011-08-12" , "https://reactome.org/content/detail/R-HSA-556833" , "Reviewed: D'Eustachio, P, 2012-05-19" , "Edited: Williams, MG, 2011-09-09" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-04-02" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/BFO_0000050>
        a       <http://www.w3.org/2002/07/owl#ObjectProperty> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "part of" .

<http://purl.obolibrary.org/obo/GO_0032991>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Macromolecular Complex" ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/BFO_0000002> .

<http://www.reactome.org/biopax/63/48887#Pathway1746>
        a       <http://purl.obolibrary.org/obo/GO_0044281> , <http://www.biopax.org/release/biopax-level3.owl#Pathway> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Metabolic processes in human cells generate energy through the oxidation of molecules consumed in the diet and mediate the synthesis of diverse essential molecules not taken in the diet as well as the inactivation and elimination of toxic ones generated endogenously or present in the extracellular environment. The processes of energy metabolism can be classified into two groups according to whether they involve carbohydrate-derived or lipid-derived molecules, and within each group it is useful to distinguish processes that mediate the breakdown and oxidation of these molecules to yield energy from ones that mediate their synthesis and storage as internal energy reserves. Synthetic reactions are conveniently grouped by the chemical nature of the end products, such as nucleotides, amino acids and related molecules, and porphyrins. Detoxification reactions (biological oxidations) are likewise conveniently classified by the chemical nature of the toxin.<p>At the same time, all of these processes are tightly integrated. Intermediates in reactions of energy generation are starting materials for biosyntheses of amino acids and other compounds, broad-specificity oxidoreductase enzymes can be involved in both detoxification reactions and biosyntheses, and hormone-mediated signaling processes function to coordinate the operation of energy-generating and energy-storing reactions and to couple these to other biosynthetic processes." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Metabolism" ;
        <http://geneontology.org/lego/hint/layout/x>
                1800 ;
        <http://geneontology.org/lego/hint/layout/y>
                50 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-556833" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-04-02" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-556833" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-04-02" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://www.reactome.org/biopax/63/48887#Pathway1794> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://www.reactome.org/biopax/63/48887#Pathway1870>
] .

<http://purl.obolibrary.org/obo/RO_0002333>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "enabled by" .

<http://www.reactome.org/biopax/63/48887#Pathway1866>
        a       <http://www.biopax.org/release/biopax-level3.owl#Pathway> , <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/GO_0008611> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "1-Acylglycerol-3-phosphate is synthesized from dihydroxyacetone phosphate, an acyl CoA molecule and NADPH + H+ in four reactions catalyzed by peroxisomal enzymes, either in the matrix of the organelle or associated with its membrane. These reactions are annotated here for palmityl (C16:0) CoA. In a series of less well-characterized reactions in the cytosol and endoplasmic reticulum, these molecules are converted to ether lipids (plasmalogens). The functions of plasmalogens are not well understood. They are an abundant subclass of phospholipids, however, and defects in their metabolism are associated with serious human disease (de Vet et al. 1999; Nagan and Zoeller 2001)." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Plasmalogen biosynthesis" ;
        <http://geneontology.org/lego/hint/layout/x>
                500 ;
        <http://geneontology.org/lego/hint/layout/y>
                50 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-556833" , "Reviewed: Jassal, Bijay, 2009-02-27" , "Authored: D'Eustachio, P, 2009-02-11 15:12:47" , "Edited: D'Eustachio, P, 2009-03-18 13:33:40" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-04-02" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-556833" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-04-02" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://www.reactome.org/biopax/63/48887#Pathway1794> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://www.reactome.org/biopax/63/48887#Pathway1797>
] .

<http://www.reactome.org/biopax/63/48887#Pathway1794>
        a       <http://www.biopax.org/release/biopax-level3.owl#Pathway> , <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/GO_0006629> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Lipids are hydrophobic but otherwise chemically diverse molecules that play a wide variety of roles in human biology. They include ketone bodies, fatty acids, triacylglycerols, phospholipids and sphingolipids, eicosanoids, cholesterol, bile salts, steroid hormones, and fat-soluble vitamins. They function as a major source of energy (fatty acids, triacylglycerols, and ketone bodies), are major constituents of cell membranes (cholesterol and phospholipids), play a major role in their own digestion and uptake (bile salts), and participate in numerous signaling and regulatory processes (steroid hormones, eicosanoids, phosphatidylinositols, and sphingolipids) (Vance & Vance 2008 - URL).<p>The central steroid in human biology is cholesterol, obtained from animal fats consumed in the diet or synthesized de novo from acetyl-coenzyme A. (Vegetable fats contain various sterols but no cholesterol.) Cholesterol is an essential constituent of lipid bilayer membranes and is the starting point for the biosyntheses of bile acids and salts, steroid hormones, and vitamin D. Bile acids and salts are mostly synthesized in the liver. They are released into the intestine and function as detergents to solubilize dietary fats. Steroid hormones are mostly synthesized in the adrenal gland and gonads. They regulate energy metabolism and stress responses (glucocorticoids), salt balance (mineralocorticoids), and sexual development and function (androgens and estrogens). At the same time, chronically elevated cholesterol levels in the body are associated with the formation of atherosclerotic lesions and hence increased risk of heart attacks and strokes. The human body lacks a mechanism for degrading excess cholesterol, although an appreciable amount is lost daily in the form of bile salts and acids that escape recycling.<p>Aspects of lipid metabolism currently annotated in Reactome include lipid digestion, mobilization, and transport; fatty acid, triacylglycerol, and ketone body metabolism; peroxisomal lipid metabolism; phospholipid and sphingolipid metabolism; cholesterol biosynthesis; bile acid and bile salt metabolism; and steroid hormone biosynthesis." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Metabolism of lipids" ;
        <http://geneontology.org/lego/hint/layout/x>
                5700 ;
        <http://geneontology.org/lego/hint/layout/y>
                50 ;
        <http://purl.obolibrary.org/obo/BFO_0000050>
                <http://www.reactome.org/biopax/63/48887#Pathway1746> ;
        <http://purl.obolibrary.org/obo/BFO_0000051>
                <http://www.reactome.org/biopax/63/48887#Pathway1797> , <http://www.reactome.org/biopax/63/48887#Pathway1866> , <http://www.reactome.org/biopax/63/48887#Pathway1883> , <http://www.reactome.org/biopax/63/48887#Pathway1795> , <http://www.reactome.org/biopax/63/48887#Pathway1798> , <http://www.reactome.org/biopax/63/48887#Pathway1870> , <http://www.reactome.org/biopax/63/48887#Pathway1867> , <http://www.reactome.org/biopax/63/48887#Pathway1884> , <http://www.reactome.org/biopax/63/48887#Pathway1830> , <http://www.reactome.org/biopax/63/48887#Pathway1833> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-556833" , "Edited: D'Eustachio, P, Joshi-Tope, G, 0000-00-00 00:00:00" , "Authored: Jassal, B, Gillespie, ME, Gopinathrao, G, D'Eustachio, P, 2007-02-02 21:56:36" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-04-02" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/RO_0002233>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "has input" .

<http://purl.obolibrary.org/obo/GO_0010025>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

<http://geneontology.org/lego/hint/layout/y>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-556833" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-04-02" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://www.reactome.org/biopax/63/48887#Pathway1794> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://www.reactome.org/biopax/63/48887#Pathway1867>
] .

<http://purl.obolibrary.org/obo/GO_0006641>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-556833" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-04-02" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://www.reactome.org/biopax/63/48887#Pathway1794> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://www.reactome.org/biopax/63/48887#Pathway1795>
] .

<http://model.geneontology.org/1198554335>
        a       <http://www.w3.org/2002/07/owl#Ontology> ;
        <http://geneontology.org/lego/modelstate>
                "development" ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-556833" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-04-02" ;
        <http://purl.org/dc/elements/1.1/title>
                "Reactome::Metabolism of lipids" .

<http://purl.obolibrary.org/obo/GO_0034389>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

<http://geneontology.org/lego/hint/layout/x>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://purl.obolibrary.org/obo/GO_0019216>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

<http://purl.obolibrary.org/obo/GO_0008611>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

<http://www.biopax.org/release/biopax-level3.owl#Pathway>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Pathway" ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/BFO_0000015> .

<http://purl.org/dc/elements/1.1/date>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-556833" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-04-02" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://www.reactome.org/biopax/63/48887#Pathway1794> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://www.reactome.org/biopax/63/48887#Pathway1866>
] .

<http://geneontology.org/lego/modelstate>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://purl.obolibrary.org/obo/CHEBI_33695>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "chebi gene" .

<http://purl.obolibrary.org/obo/RO_0001025>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "located in" .

<http://purl.obolibrary.org/obo/GO_0003674>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Molecular Function" .

<http://www.reactome.org/biopax/63/48887#Pathway1798>
        a       <http://www.biopax.org/release/biopax-level3.owl#Pathway> , <http://purl.obolibrary.org/obo/GO_0006631> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "The synthesis and breakdown of fatty acids are a central part of human energy metabolism, and the eicosanoid class of fatty acid derivatives regulate diverse processes in the body (Vance & Vance 2008 - URL). Processes annotated in this module include the synthesis of fatty acids from acetyl-CoA, mitochondrial and peroxisomal breakdown of fatty acids, and the metabolism of eicosanoids and related molecules." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Fatty acid metabolism" ;
        <http://geneontology.org/lego/hint/layout/x>
                3100 ;
        <http://geneontology.org/lego/hint/layout/y>
                50 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Edited: Jassal, B, Gillespie, ME, Gopinathrao, G, D'Eustachio, P, 2007-02-02 21:56:36" , "Authored: Jassal, B, Gillespie, ME, Gopinathrao, G, D'Eustachio, P, 2007-02-02 21:56:36" , "Reviewed: Jassal, B, Gillespie, ME, Gopinathrao, G, D'Eustachio, P, 2007-02-02 21:56:36" , "https://reactome.org/content/detail/R-HSA-556833" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-04-02" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-556833" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-04-02" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://www.reactome.org/biopax/63/48887#Pathway1794> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://www.reactome.org/biopax/63/48887#Pathway1884>
] .

<http://purl.obolibrary.org/obo/RO_0002429>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "involved in positive regulation_of" .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-556833" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-04-02" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000050> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://www.reactome.org/biopax/63/48887#Pathway1794> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://www.reactome.org/biopax/63/48887#Pathway1746>
] .

<http://purl.obolibrary.org/obo/RO_0002024>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "directly positively regulated by" .

<http://purl.obolibrary.org/obo/BFO_0000066>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "occurs in" .

<http://www.biopax.org/release/biopax-level3.owl#Reaction>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Reaction" ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/BFO_0000015> .

<http://www.reactome.org/biopax/63/48887#Pathway1830>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://www.biopax.org/release/biopax-level3.owl#Pathway> , <http://purl.obolibrary.org/obo/GO_0006641> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Fatty acids derived from the diet and synthesized de novo in the liver are assembled into triglycerides (triacylglycerols) for transport and storage. Synthesis proceeds in steps of conversion of fatty acyl-CoA to phosphatidic acid, conversion of phosphatidic acid to diacylglycerol, and conversion of diacylglycerol to triacylglycerol (Takeuchi & Reue 2009).<br>Hydrolysis of triacylglycerol to yield fatty acids and glycerol is a tightly regulated part of energy metabolism. A central part in this regulation is played by hormone-sensitive lipase (HSL), a neutral lipase abundant in adipocytes and skeletal and cardiac muscle, but also abundant in ovarian and adrenal tissue, where it mediates cholesterol ester hydrolysis, yielding cholesterol for steroid biosynthesis. The hormones to which it is sensitive include catecholamines (e.g., epinephrine), ACTH, and glucagon, all of which trigger signaling cascades that lead to its phosphorylation and activation, and insulin, which sets off events leading to its dephosphorylation and inactivation (Kraemer & Shen 2002).<p>The processes of triacylglycerol and cholesterol ester hydrolysis are also regulated by subcellular compartmentalization: these lipids are packaged in cytosolic particles and the enzymes responsible for their hydrolysis, and perhaps for additional steps in their metabolism, are organized at the surfaces of these particles (e.g., Brasaemle et al. 2004)." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Triglyceride metabolism" ;
        <http://geneontology.org/lego/hint/layout/x>
                4400 ;
        <http://geneontology.org/lego/hint/layout/y>
                50 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-556833" , "Authored: Jassal, B, Gillespie, ME, Gopinathrao, G, D'Eustachio, P, 2007-02-02 21:56:36" , "Edited: Jassal, B, Gillespie, ME, Gopinathrao, G, D'Eustachio, P, 2007-02-02 21:56:36" , "Reviewed: Jassal, B, Gillespie, ME, Gopinathrao, G, D'Eustachio, P, 2007-02-02 21:56:36" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-04-02" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.org/dc/elements/1.1/contributor>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://purl.obolibrary.org/obo/RO_0002408>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "directly inhibits (process to process)" .

<http://www.reactome.org/biopax/63/48887#Pathway1884>
        a       <http://www.biopax.org/release/biopax-level3.owl#Pathway> , <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/GO_0046950> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Acetoacetate, beta-hydroxybutyrate, and acetone collectively are called ketone bodies. The first two are synthesized from acetyl-CoA, in the mitochondria of liver cells; acetone is formed by spontaneous decarboxylation of acetoacetate. Ketone body synthesis in liver is effectively irreversible because the enzyme that catalyzes the conversion of acetoacetate to acetoacetyl-CoA is not present in liver cells.<P>Ketone bodies, unlike fatty acids and triglycerides, are water-soluble. They are exported from the liver, and are taken up by other tissues, notably brain and skeletal and cardiac muscle. There, they are broken down to acetyl-CoA which is oxidized via the TCA cycle to yield energy. In a normal person, this pathway of ketone body synthesis and utilization is most active during extended periods of fasting. Under these conditions, mobilization and breakdown of stored fatty acids generates abundant acetyl-CoA acetyl-CoA in liver cells for synthesis of ketone bodies, and their utilization in other tissues minimizes the demand of these tissues for glucose (Sass 2011)." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Ketone body metabolism" ;
        <http://geneontology.org/lego/hint/layout/x>
                3750 ;
        <http://geneontology.org/lego/hint/layout/y>
                50 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Authored: Gopinathrao, G, 2003-07-23 10:32:00" , "https://reactome.org/content/detail/R-HSA-556833" , "Edited: Gopinathrao, G, 2003-07-16 00:00:00" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-04-02" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-556833" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-04-02" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://www.reactome.org/biopax/63/48887#Pathway1794> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://www.reactome.org/biopax/63/48887#Pathway1833>
] .

<http://purl.obolibrary.org/obo/RO_0002430>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "involved in negative regulation_of" .

<http://purl.obolibrary.org/obo/GO_0044281>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

<http://www.reactome.org/biopax/63/48887#Pathway1797>
        a       <http://www.biopax.org/release/biopax-level3.owl#Pathway> , <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/GO_0034389> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Lipid droplets (LDs) are cytosolic structures found in cells of all eukaryotes, comprising a monolayer of phospholipids surrounding a core of uncharged lipids such as triglyceride (TAG) and sterol esters. CIDEA, CIDEB and CIDEC were first studied for their roles in promotion of apoptosis but they are also known to play a role in energy metabolism. CIDEA and C bind to lipid droplets and regulate their enlargement, thereby restricting lipolysis and favouring storage (by promoting net neutral lipid transfer from smaller to larger lipid droplets) (Gao & Goodman 2015). LD formation involves the partitioning of neutral lipids from their site of synthesis at the endoplasmic reticulum (ER) to the cytosol. The fat storage-inducing transmembrane proteins 1 and 2 (FITM1 and FITM2), associated with the ER membrane, mediate binding and partitioning of TAGs into LDs. The short-chain dehydrogenases/reductases (SDR) family is a large family of NAD- or NADP-dependent oxidoreductase enzymes. 17-beta-hydroxysteroid dehydrogenase 13 (HSD17B13) is a recently-discovered enzyme of unknown physiological function that is associated with lipid droplets and significantly upregulated in patients with nonalcoholic fatty liver disease. Hypoxia-inducible lipid droplet-associated protein (HILPDA) is a lipid droplet protein and stimulates intracellular lipid accumulation." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Lipid particle organization" ;
        <http://geneontology.org/lego/hint/layout/x>
                5050 ;
        <http://geneontology.org/lego/hint/layout/y>
                50 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Edited: Jassal, Bijay, 2016-02-11" , "https://reactome.org/content/detail/R-HSA-556833" , "Reviewed: D'Eustachio, Peter, 2016-04-05" , "Authored: Jassal, Bijay, 2016-02-11" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-04-02" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://www.biopax.org/release/biopax-level3.owl#Protein>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Protein" ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/BFO_0000002> .

<http://purl.obolibrary.org/obo/GO_0006665>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-556833" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-04-02" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://www.reactome.org/biopax/63/48887#Pathway1794> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://www.reactome.org/biopax/63/48887#Pathway1883>
] .

<http://purl.org/dc/elements/1.1/title>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://purl.obolibrary.org/obo/RO_0002428>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "involved in regulation of" .

<http://purl.obolibrary.org/obo/RO_0002023>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "directly negatively regulated by" .

<http://purl.obolibrary.org/obo/GO_0046950>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/GO_0008150> .
